A Phase 1 Study of M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma

Grant

Date/time Interval

  • May 1, 2017 - April 30, 2020
  • Total Award Amount

  • 1604566.00
  • Direct Costs

  • 1158966.00
  • Sponsor Award Id

  • R01CA217179
  • Contributor

  • Aban, Inmaculada   Investigator  
  • Cutter, Gary   Investigator  
  • Fathallah-Shaykh M.D., Ph.D., Hassan   Investigator  
  • Gillespie, George   Investigator  
  • Guthrie M.D., Barton   Investigator  
  • Han, Xiaosi   Investigator  
  • Lamb Jr. Ph.D., Lawrence   Investigator  
  • Leavenworth Ph.D., Jianmei   Investigator  
  • Lobbous, Mina   Investigator  
  • Markert M.D., M.P.H., James   Principal Investigator  
  • Miller, C. Ryan   Investigator  
  • Nabors M.D., Louis   Investigator  
  • Nakano M.D., Ph.D., Ichiro   Investigator  
  • Riley, Kristen   Investigator